Analyst firms · Robert W. Baird · AGEN

Robert W. Baird AGEN price target and rating history

Agenus Inc. (AGEN) · Health Care

Robert W. Baird rates Agenus Inc. (AGEN) Neutral with a $8 price target, as of its latest action on Jul 19, 2024. It has published 3 rating actions on AGEN since June 2023, including 0 upgrades and 1 downgrade. Across 3 firms with a AGEN price target in the last 12 months, the median target is $30.

Current rating
Neutral
Price target
$8
Median target, all firms
$30
Actions on AGEN
3

Robert W. Baird price target on AGEN

$80$44$8202420252026
Robert W. Baird price target on AGEN, each point a stated target, June 2023 to July 2024.

Every Robert W. Baird rating on AGEN

How other firms rate AGEN

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Rodman & RenshawBuy$19Sep 28, 2026
Chardan Capital MarketsBuy$40Sep 18, 2026
H.C. WainwrightBuy$30Jul 13, 2026

Questions about Robert W. Baird and AGEN

What is Robert W. Baird's price target for AGEN?
Robert W. Baird's latest stated price target for Agenus Inc. (AGEN) is $8, from its action on Jul 19, 2024.
What is Robert W. Baird's rating on AGEN?
Robert W. Baird rates AGEN Neutral, a neutral rating, as of Jul 19, 2024.
When did Robert W. Baird last change its view on AGEN?
On Jul 19, 2024, Robert W. Baird downgrades to Neutral from Outperform, price target $35 to $8.
How does Robert W. Baird's AGEN target compare with other analysts?
Across 3 firms with a AGEN price target in the last 12 months, the median target is $30.

More AGEN rating histories

All Robert W. Baird ratingsAGEN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.